Demineralized Bone Matrix Market Size, Share And Trends Analysis Report, By Product (Putty, Fiber, Paste), By Application (Spinal Fusion, Dental, Joint Reconstruction), By End Use, By Region, And Segment Forecasts, 2025 - 2030

Demineralized Bone Matrix Market Size, Share And Trends Analysis Report, By Product (Putty, Fiber, Paste), By Application (Spinal Fusion, Dental, Joint Reconstruction), By End Use, By Region, And Segment Forecasts, 2025 - 2030


Wearable Medical Devices Market Growth & Trends

The global wearable medical devices market size is expected to reach USD 168.29 billion by 2030, registering a CAGR of 25.53% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing growth driven by an increasing demand for high-tech products and the growing trend of continuous health monitoring.

The rising obesity rate and a heightened awareness of physical fitness, is motivating individuals to engage in workouts and adopt fitness-related activities. Wearable devices like smartwatches and smart bands play a crucial role in monitoring various fitness parameters, including calories burned, step count, heart rate, and distance covered. Companies such as Google, Fitbit, Apple, and Nike are actively launching innovative products, particularly focusing on smartwatches and wristbands, contributing to a surge in product availability.

The COVID-19 pandemic has positively impacted the market, driven by the increased demand for telemedicine. WHO guidelines promoting social distancing and discouraging public gatherings have led to a preference for telemedicine among physicians, enabling remote patient treatment without the risk of virus transmission. The growth of telemedicine, coupled with the integration of artificial intelligence (AI) into its systems, has further propelled the expansion of the wearable medical device market.

Wearable Medical Devices Market Report Highlights
  • The diagnostic devices segment led the market with the largest revenue share of 61.32% in 2024. The increasing prevalence of neurological disorders is a primary driver for the growth of this segment.
  • Based on site, the strap/clip/bracelet segment led the market with the largest revenue share of 51.6% in 2024 and is likely to remain dominant throughout the forecast period.
  • Based on application, the home healthcare segment led the market with the largest revenue share of 53.1% in 2024, due to the increasing geriatric population increasing prevalence rates of target diseases, and the growing need to curb healthcare expenditure as an economically viable initiative are some of the factors responsible for market growth.
  • Based on grade type, the consumer-grade segment led the market with the largest revenue share of 77.30% in 2024. These devices offer user-friendly features, focusing on personal health and fitness tracking, making them widely popular among consumers.
  • Based on the distribution channel, the pharmacy segment led the market with the largest revenue share of 39.34% in 2024. This dominance is attributed to the widespread accessibility of pharmacies, offering consumers a convenient avenue to purchase these devices.
  • North America wearable medical devices market dominated with the largest revenue share of 35.76% in 2024, owing to the growing prevalence of cardiovascular disorders, diabetes, and cancer within this region.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product type outlook
2.2.2. Application outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Demineralized Bone Matrix Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Demineralized Bone Matrix (DBM): Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Regulatory Framework
Chapter 4. Demineralized Bone Matrix Market Segment Analysis, By Product Type, 2018-2030 (USD Million)
4.1. Definition and Scope
4.2. Product Type Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Global Demineralized Bone Matrix (DBM) Market, by Product Type, 2018 to 2030
4.5. Putty
4.5.1. Putty market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Fiber
4.6.1. Fiber market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Sponge
4.7.1. Sponge market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Paste
4.8.1. Paste market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Gel
4.9.1. Gel market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Others
4.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Demineralized Bone Matrix Market Segment Analysis, By Application, 2018-2030 (USD Million)
5.1. Definition and Scope
5.2. Application Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. Global Demineralized Bone Matrix (DBM) Market, by Application, 2018 to 2030
5.5. Spinal Fusion
5.5.1. Spinal fusion market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Dental
5.6.1. Dental market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Joint Reconstruction
5.7.1. Joint reconstruction market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Hand, foot, and ankle
5.8.1. Hand, foot, and ankle market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Long Bone
5.9.1. Long bone market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Craniomaxillofacial
5.10.1. Craniomaxillofacial market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Demineralized Bone Matrix Market Segment Analysis, By End Use, 2018-2030 (USD Million)
6.1. Definition and Scope
6.2. End Use Market Share Analysis, 2024 & 2030
6.3. Segment Dashboard
6.4. Global Demineralized Bone Matrix (DBM) Market, by End Use, 2018 to 2030
6.5. Hospitals
6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD million)
6.6. Outpatient facilities
6.6.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.2. Specialized Orthopedic Clinics
6.6.2.1. Specialized orthopedic clinics market estimates and forecasts, 2018 to 2030 (USD Million)
6.6.3. Ambulatory Surgical Centers
6.6.3.1. Ambulatory surgical centers clinics market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Demineralized Bone Matrix Market Segment Analysis, By Region, By Product Type, By Application, By End Use, 2018- 2030 (USD Million)
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Regional Market Snapshot
7.4. Demineralized Bone Matrix (DBM) Market Share by Region, 2024 & 2030
7.5. North America
7.5.1. North America demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.5.2. U.S.
7.5.2.1. U.S. demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.5.3. Canada
7.5.3.1. Canada demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Mexico demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.6. Europe
7.6.1. Europe demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.6.2. UK
7.6.2.1. UK demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.6.3. Germany
7.6.3.1. Germany demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.6.4. France
7.6.4.1. France demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.6.5. Italy
7.6.5.1. Italy demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.6.6. Spain
7.6.6.1. Spain demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.6.7. Norway
7.6.7.1. Norway demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.6.8. Sweden
7.6.8.1. Sweden demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.6.9. Denmark
7.6.9.1. Denmark demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Japan demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.7.2. China
7.7.2.1. China demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.7.3. India
7.7.3.1. India demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Australia demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. South Korea demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Thailand demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Brazil demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.8.2. Argentina
7.8.2.1. Argentina demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. South Africa demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Saudi Arabia demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.9.3. UAE
7.9.3.1. UAE demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Kuwait demineralized bone matrix (DBM) market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Company Profiles
8.3.1. Zimmer Biomet
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Medtronic Plc
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. DePuy Synthes
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Stryker Corporation
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Arthrex Inc
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. SeaSpine
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Globus Medical
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Berkeley Advanced Biomaterials
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. XTANT MEDICAL
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. LifeNet Health
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings